Spain· ES:1171225001IP
SYMTUZA 800 MG/150 MG/200 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing darunavir + cobicistat + emtricitabina + tenofovir alafenamida, registered in Spain by Janssen-Cilag International N.V.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- darunavir + cobicistat + emtricitabina + tenofovir alafenamida
- Manufacturer
- Janssen-Cilag International N.V
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Darunavir + cobicistat + emtricitabina + tenofovir alafenamida in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaSYMTUZAJANSSEN INC
- SwitzerlandSymtuza, FilmtablettenJanssen-Cilag AG
- United KingdomSymtuza 800mg/150mg/200mg/10mg tabletsJanssen-Cilag Ltd
- PolandSymtuzaJanssen-Cilag International N.V.
- United StatesSymtuzaJanssen Products LP
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Symtuza
- Liechtenstein · Symtuza
- Norway · Symtuza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc98610c-9396-4874-b057-21773fe1d0ad GET /v1/drugs/cc98610c-9396-4874-b057-21773fe1d0ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1635867639000}",
"nregistro": "1171225001IP",
"substance": "darunavir + cobicistat + emtricitabina + tenofovir alafenamida"
}See everything about darunavir + cobicistat + emtricitabina + tenofovir alafenamida.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.